bee_admin – AcelaBio

Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials

LONDON, ON, November 8, 2023 – Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine and artificial intelligence (AI)-enabled digital pathology solutions for metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH) clinical trials. This collaboration will enable clinical trial sponsors to quantify the… Continue reading Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials

Day in the Life at AcelaBio with Vicky Lor

At AcelaBio, our employees come first. We engage inspired and talented individuals who help us shape the future of delivering reliable, high-quality clinical research services. Over the past several months, the team has grown and has expanded their laboratory service, and in celebrating this, we wanted to highlight one of our employees. Vicky Lor, Histology… Continue reading Day in the Life at AcelaBio with Vicky Lor

AcelaBio Accredited by College of American Pathologists

San Diego, CA, USA, Release: September 15, 2022 – AcelaBio (US) Inc., a contract research organization delivering histopathology and precision medicine laboratory services for global clinical trials, achieved its accreditation by the College of American Pathologists (CAP). CAP accreditation indicates that the laboratory meets stringent requirements of quality, accuracy, and consistency of test results to ensure… Continue reading AcelaBio Accredited by College of American Pathologists